Insider trades
Norry Elliot, Chief Officer of Adaptimmune Therapeutics ADAPY, has filed 0 purchases and 13 sales on the open market. The latest trade was on 25/02/20.
Norry Elliot
Chief Medical Officer
- First filing
- 23/01/04
- Trades
- 20 trades
- Buys / sales
- 0 / 13
- 12-month net buying
- No record
- Last trade
- 25/02/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/01/17 | 25/01/17 | 5,584 sh | $0.58 | $3,238.72 | −42.6% | |
ADAPY | Open-market sale | 25/01/13–25/01/15 | 25/01/15 | 22,195 sh3 trades | $0.58avg. | $12,898.99 | −61.7% |
ADAPY | Open-market sale | 24/01/16–24/01/17 | 24/01/17 | 20,563 sh3 trades | $0.68avg. | $14,051.65 | −51.6% |
ADAPY | Open-market sale | 24/01/11–24/01/12 | 24/01/12 | 11,808 sh2 trades | $0.85avg. | $9,996.71 | −49.9% |
| Open-market sale | 23/01/17 | 23/01/17 | 2,159 sh | $1.86 | $4,015.74 | −38.2% | |
ADAPY | Open-market sale | 23/01/11–23/01/12 | 23/01/12 | 11,292 sh2 trades | $1.72avg. | $19,463.04 | −48.1% |
| Open-market sale | 23/01/04 | 23/01/04 | 876 sh | $1.69 | $1,480.44 | −39.2% |